Dr. Bernthal is the Interim Chair and Executive Medical Director of UCLA Department of Orthopaedic Surgery and Chief of the Division of Musculoskeletal Oncology. He is a surgeon-scientist who leads one of the busiest sarcoma practices in the country while leading an NIH-funded basic science laboratory.
Dr. Bernthal’s laboratory developed and published a mouse model of post-arthroplasty infection that has become widely used by academics, regulatory officials, and industry. The model leverages a panel of bioluminescent bacteria to allow longitudinal real-time in vivo tracking of infection, while using immunomodulated mice so that fluorescence imaging can track immune response. This model has produced twenty peer-reviewed papers, numerous grants, and multiple awards, but perhaps most importantly, has been adopted by scientists from industry, academia, and the Food and Drug Administration. Dr. Bernthal was selected to lead the Orthopaedic Research Society’s 2017 symposium on “The Infected Implant” and represent the American Orthopaedic Association as an American-British-Canadian Traveling Fellow in 2017. He serves on the Executive Board of the Musculoskeletal Tumor Society and on the Board of Trustees for the Orthopaedic Research and Education Foundation.
Dr. Bernthal was born and raised in Washington D.C. He played Varsity Basketball at Princeton University while studying political science. He earned his medical degree from Cornell Medical School and did his residency at UCLA. He completed two fellowships -one in Orthopedic Research at UCLA and the other at the Huntsman Cancer Institute - and has been on faculty at UCLA since 2013.

A/Prof Paul Stalley graduated with Honours at the University of NSW and for the last 35 years has been an Orthopaedic Surgeon at Royal Prince Alfred Hospital, Sydney and The Children’s Hospital, Westmead, Sydney. Prior to appointment at Royal Prince Alfred he trained as a lecturer in Orthopaedics at The University of London and at Stanmore in the United Kingdom. He has extensive experience in joint replacement surgery for osteoarthritis and has provided spinal surgical services to Royal Prince Alfred Hospital.
For 25 years until 2021 he was Head of the Bone and Soft Tissue Sarcoma Unit at Royal Prince Alfred Hospital, Sydney, dealing with some 95% of primary bone sarcomas in the NSW population. Current interests especially involve the use of extracorporeal irradiation and reimplantation and, most recently, the use of 3D printed titanium implants for limb salvage and joint revision surgery.

Education

• 10/1994 | Beginning of the academic studies in human medicine
• 11/2000 | German Examination
• 11/1998 | Step 1 of the United States Medical Licensing / Examination
• 09/2001 | Step 2 of the United States Medical Licensing / Examination

Employment History

• 12/2000 - 11/2001 | Resident physician in the Department of Traumatology, University Hospital of Ulm (Prof. Dr. med. L. Kinzl)
• 01/2002 - 12/2007 | Resident physician in the Department of Orthopaedics, University Hospital of Muenster (Prof. Dr. med. W. Winkelmann)
• 12/2007 | Senior physician in the Department of Orthopaedics, University Hospital of Muenster (Prof. Dr. med. W. Winkelmann)
• 09/2008 – 03/2018 | Head of the Department Tumor- and Revision Surgery in the Department of Orthopaedics and Tumor Orthopaedics, University Hospital of Muenster (Professor Dr. med. G. Gosheger)
• Since 04/2018 | Head of the Department of Musculoskeletal Surgical Oncology, University Hospital of Essen

Further Qualifications

• 11/2007: Postdoctoral lecture qualification: Lack of toxicological side-effect in silver- coated megaprostheses

Prof. Dr. Jendrik Hardes studied medicine at the Westfälische Wilhelms-Universität Münster from 1994-2000. From 2000 to 2006 he completed his specialist training in the Clinic for General Orthopedics at the University Hospital in Münster and habilitated with the topic "Lack of toxicological side effect in silver-coated megaprostheses" in 2007. Between 2008 and 2018 he was head of the tumor orthopedics section in the Clinic for General Orthopedics and Tumor Orthopedics at the University Hospital in Münster. Together with Prof. Dr. Arne Streitbürger he has been the director of the Clinic for Tumor Orthopedics at the West German Tumor Center of the University Hospital Essen since 2018.
Prof. Dr. Jendrik Hardes has authored over 160 papers in peer reviewed journals. His scientific focus is on clinical, basic scientific and translational research in the field of tumor orthopedics and material sciences. He is an active member of several national and international societies. He is currently an active board member of EMSOS.

Born in Italy in 1983, he obtained the medical degree cum laude at University of Bologna in 2008. He obtained Board certification in Orthopedic Surgery at University of Bologna and Rizzoli Orthopedic Institute in 2014, followed by PhD in Oncology and Experimental Pathology at University of Bologna in 2016. His main field of interest is spine surgery and surgery for musculoskeletal tumors: he collaborated for books (editor of 3 books), chapters (contributors of 36 published book chapters), and numerous scientific papers (125 published papers available on Pubmed and Scopus, about 2000 citations, H-index 24). Peer-reviewer for about 30 journals. He has been in the faculty of several international courses of musculoskeletal pathology and he has held talks in many prominent international meetings including SICOT, MSTS, ISOLS, AAOS, EFORT (n. 180 presentations). He is coauthor of more than 300 meeting abstracts. He was awarded for his scientific activity from EFORT, SIOT, EMSOS and ISOLS. He is Vice-Chair of the SICOT Tumours Committee, ISOLS delegate for virtual ICM on VTE, Task force member of the European Orthopaedics & Traumatology Education Platform (EOTEP), Faculty member and abstract reviewer for EFORT and SICOT.

Born in Bologna on april 1st 1964, he graduated in Medicine and Surgery in 1988 and he completed the Residency School in Orthopaedic and Traumatology at the Rizzoli Orthopedic Institute in Bologna, in 1993.
From 1989 to 1993 he attended the 1st University Clinic and the Laboratory of Oncologic Research of the Rizzoli Orthopedic Institute, acquiring experience in the diagnosis and treatment of musculoskeletal tumors and participating in several projects of basic science and clinical research.
In 1994, he resulted the winner of the "Howard Hatcher Pathology Fellowship", issued by the "American Orthopedic Association". During the same year, he completed a research Fellowship in Orthopedic Oncology, in the Department of Orthopedics at the University of Florida in Gainesville US, directed by Prof. W. Enneking, developing research projects on reconstructive techniques in Orthopedic Oncology with particular regard to allogenic bone grafts.
In 1997, he attended, as Clinical Observer, the Orthopedic Service of the Department of Surgery of Memorial Sloan-Kettering Cancer Center of New York, U.S., directed by Dr. John Healey and the Hip and Knee Service of Hospital for Special Surgery in New York U.S.
From 1995 to 2014, he was Consultant of Orthopedics and Traumatology (deputy Director since 2001) in the Department of Orthopaedic Oncology and Reconstructive Surgery, at the “Azienda Ospedaliera Universitaria Careggi” in Florence.
From 2014 to 2016, he was the Director of the Department of Traumatology and General Orthopedics at the “Azienda Ospedaliera Universitaria Careggi” in Florence, a Trauma Center regional Hub.
From 2016 to date, he is the Director of the Department of Orthopaedic Oncology and Reconstructive Surgery at the “Azienda Ospedaliera Universitaria Careggi” in Florence, a national referral Center for the treatment of musculoskeletal tumors.
From 2016 to date, he is the Coordinator of the Multidisciplinary Oncologic Group for Bone and Soft Tissue Tumors of Azienda Ospedaliera Universitaria Careggi in Florence.
From 2015 to 2021, he was Associate Professor at the University of Florence, at the Department of Surgery and Translational Medicine up to December 2018 and at the Department of Health Science from January 2019.
From 2021 to date, he is Full Professor at the University of Florence, at the Department of Health Science.
During his career, he has performed more than 5000 surgical procedures of general orthopedics, traumatology and orthopedic oncology as 1st surgeon.
He was the author or co-author of 207 scientific publications on books, national and international journals, and of more than 340 abstracts published in "Abstract books" or national and international journals. Currently, he is the Director of a national referral Center for the treatment of bone and soft tissue tumors and his main field of clinical and research interest is orthopaedic reconstructive surgery. In particular, his expertise focuses on reconstructions of osteoarticular bone defects following oncologic resections, trauma or prosthetic failures, pelvic surgery in both oncologic resections and trauma, skeletal reconstructions with prostheses or bone grafts.

I am Dr. Miguel Angel Clara-Altamirano, Orthopedic Oncologist, Master Degree in Medical Science. Physician attached to the Department of Skin, Soft Tissues, and Bone Tumors of the National Cancer Institute of Mexico. Professor of the Fellowship in Orthopedic Oncology at the National Cancer Institute of Mexico.

Dr. D’Amato an Associate Professor of Medicine at the Sylvester Comprehensive Cancer Center at the University of Miami, where she serves as a Sarcoma Medical Oncologist, Assistant Director of Clinical Research, and Medical Director of the Comprehensive Treatment Unit
She received her B.S. from University of Miami, M.D. from the University Of Miami School Of Medicine and completed her internal medicine residency at Jackson Memorial Hospital/University of Miami. In 2003, during her last year of hematology/oncology fellowship at Moffitt Cancer Center in Tampa, FL, she began her focus GIST and other sarcomas. In addition to her clinical service, she is also involved in clinical trials for GIST and other sarcoma and is a co-director of the oncology pathway in a newly implemented curriculum for the University Of Miami Miller School Of Medicine.

Dr. Dimosthenis Andreou is a Consultant Orthopedic Oncologist at the Medical University of Graz, and specialises in the surgical treatment of bone and soft tissue sarcoma. He is currently the Chairman of the Surgical Working Group of the Euro-Ewing-Consortium and Co-Chair of the Bone Sarcoma Working Group of the German Sarcoma Foundation, as well as an active member of several national and international societies and groups.
Dr. Andreou has authored over 70 publications in peer reviewed journals on orthopedics and orthopedic oncology, and has written several book chapters in the field. His main research interests include the optimization of local therapy in the context of multidisciplinary treatment of bone and soft tissue sarcomas, as well as the Health-Related Quality of Life aspects of treatment.

Dr. Duan a professor of Orthopaedic Surgery. Dr. Duan’s research is focused on (1) characterizing molecular mechanisms governing growth and proliferation of sarcoma cells, (2) studying the mechanisms of multidrug resistance, and (3) identifying novel therapeutic targets and delivery systems to improve treatment in sarcoma.

Medical State Board Germany 1968, California State Board 1977, Switzerland 1986
Board Certification Pediatrics Germany, Orthopaedic Ssurgery Germany and Switzerland.

Formerly Head Tumor Orthopaedics University Hospital Balgrist, since 2008 in Private Practice.

Past president Asociación Argentina de Ortopedia Oncológica (2020-2021)
Isols member 385 (since 2015)
2019 AAOS International Scholars. Orthopedic Oncology. University of Chicago. Illinois, USA
PI in the, PARITY STUDY (parity investigator group), SAFETY and SELNET
Fellowship Orthopedic Oncology: Hospital Universitario Austral, Asociacion Argentina de Ortopedi Oncologica
Research fellowship Rush presbyterian medical center (dr gitelis)
Visiting physician at: Mayo clinic (Dr Sim), MSKCC (Dr Fabbri), RHO (Dr Jeys)

Dr. Michelle Ghert is a Professor of Orthopaedic Surgery at McMaster University in Canada.. She runs a clinical practice specializing in the management of patients with primary musculoskeletal tumors. Her research interests include the design and implementation of multi-center trials in the field of orthopaedic oncology with the goal of advancing the clinical care of patients with musculoskeletal tumors.

Dr Praveen Gupta is a Consultant Orthopedic Oncologist and Chief of The Department Orthopedic Oncology at Bhagwan Mahaveer Cancer Hospital & Research Center, Jaipur, India. He has Diploma in Tissue Banking from NUHS, Singapore. He had been a clinical trainee at JFCR Tokyo and TMH Mumbai. He is an active Member of various National and International Societies of Orthopedic and musculoskeletal Oncology and had organized many CMEs and conferences based on Orthopedic Oncology and develop well functional department for Bone and Soft tissue tumors management since 2015 at his state. He is actively involved in clinical research and is the principal investigator in many studies.

His vision is to explore new biological limb salvage options with combination of advances in present era and old biological reconstructive modalities learnt from his Mentor “Padam Shree Professor S S Yadav”.

His specialist interests include safe surgical margins, Recycled tumor bone and roles of fibula to biological reconstruction for limb salvage as composite and primary modalities.

He graduated from Kanazawa University medical school in 1983. He started to study and work in the musculoskeletal oncology field from 1986, and also was involved into limb reconstruction with external fixator from 1989.

He developed "caffeine-potentiated chemotherapy for bone and soft-tissue sarcomas", "tumor reconstruction using distraction osteogenesis procedure", "tumor reconstruction using tumor-bearing autogenous bone treated by liquid nitrogen", "antimicrobial iodine coating for orthopedic implants", “cryo-immunological treatment”, “musculoskeletal regeneration with adipose tissue derived stem cells” and more. He also achieved numerous basic researches in both orthopaedics and oncology fields.

He is now the ex-president of "International Society of Limb Salvage (ISOLS)" and the current president of "ASAMI-Japan" and a director of many Japanese medical societies.

Furthermore, he has now more than 750 English publications regarding tumor biology, tumor surgery, trauma, distraction osteogenesis, pediatric orthopedics, adult reconstruction, spine surgery, trauma, hand surgery, foot and ankle surgery, regenerative medicine, and so on.

Anusha Kalbasi is the chief of adult and pediatric sarcoma radiotherapy at UCLA. He is a physician-scientist bridging early phase clinical trials and laboratory investigations to develop l immune-based approaches for the treatment of patients with sarcoma and melanoma. Anusha is a graduate of the David Geffen School of Medicine at UCLA, where he was an HHMI Research Scholar at the National Cancer Institute. Anusha then completed his clinical training and post-doctoral research at the University of Pennsylvania, as well as a second post-doctoral fellowship at UCLA before taking his current role.

Graduated Hadassah Medical School Israel (1978), Residency orthopaedic surgery Hadassah Hospital (1978-1985). Two years fellowship bone pathology, orthopaedic oncology, total joint replacement Hospital for Joint Disease (1985- 1987). Chief orthopaedic oncology Mount Sinai hospital (1992-1995). Professor of Orthopaedic Surgery NYU Medical Center, Chief orthopaedic oncology hospital for joint diseases (1996-2011). Chief orthopaedic oncology North shore /Long Island Jewish hospitals, professor of orthopaedic surgery Zucker medical school Hofstra University at Northwell health, NY (2012-2022)

Doctor Kenan Samuel is a gifted tumor surgeon recognized nationally and internationally, specializing in Joint preservation limb sparing surgery in children and adults with malignant bone tumors, utilizing biological, and prosthesis reconstruction.

Eisuke Kobayashi serves as Head of Musculoskeletal Oncology at the National Cancer Center Hospital. He has been involved in translational research aiming to develop new treatment strategies for sarcomas. Prior to his current position, Dr. Kobayashi was a Medical Staffer at the National Cancer Center Hospital, as well as a Research Fellow and a Clinical Resident, respectively. Dr. Kobayashi also served as a Research Fellow at the Orthopedics Division and Sarcoma Molecular Biology Laboratory at Massachusetts General Hospital in connection with Harvard University. Dr. Kobayashi earned his MD at Keio University and his PhD in Orthopedics at Keio Graduate University.

I received the Medical Degree from the University of Ioannina, and completed a 6-year Orthopaedic residency program at the Department of Orthopaedic Surgery, Ioannina University, Greece (2007). In 2007, I submitted my Doctoral thesis at the University of Ioannina. I received a scholarship from the Hellenic Orthopaedic Surgery Association (2008) and an International Traveling Fellowship from the American Society for Surgery of the Hand (ASSH-2011). I was trained in the field of adult and children Orthopaedic Oncology and Hand Surgery at the DUKE Medical Center NC USA, Harvard Children’s Hospital Boston, Brown University USA, Shriners Hospital for Children Philadelphia USA, Institute Orthopedico Rizzoli Bologna Italy, Institute di Tumori, Milan Italy. I served as an Attending Orthopaedic Surgeon (2009-2013) at the Department of Orthopaedic Surgery Hospital of Volos and University Hospital of Larissa, Thessaly, Greece. In 2013, I was elected as Lecturer at the Medical School of the National and Kapodistrian University of Athens, Greece, as Assistant Professor in 2015 and Associate Professor of Orthopaedic Surgery in 2020.

• President of the Hellenic Society for Surgery of the Hand 2016-2017.
• Regional Editor of the American Journal Hand Surgery GO.
• SICOT, Greek National Delegate since 2020

Prof. Dr. Andreas Leithner (born 1974) is head of the Department of Orthopaedics and Trauma (since 2017) and full professor for orthopaedic surgery (since 2012) at the Medical University of Graz, Austria. He has been appointed Secretary of the European Muskuloskeletal Oncology Society (EMSOS) in 2012, is the former President of the Austrian Muskuloskeletal Oncology Society (AMSOS) and the former President of the Austrian Society of Orthopaedic Surgeons (ÖGO).
Born in Vienna, he studied medicine there and went to Graz in 2000, soon specializing in the field of orthopaedic oncology. He became “Dozent” in 2005 and interim head of the Orthopaedic Department in 2010 until 2012, when he became head of the department (till 2016). Since 2017 he is the head of the new Department of Orthopaedics and Trauma at the Medical University of Graz. Since 2018 he additionally serves as Vice Rector for Clinical Affairs at the Medical University of Graz.
He is author / co-author of >350 PubMed listed publications, >1200 oral / poster presentations and has acted as a reviewer for 11 funding organizations and 62 international journals.

Dr. Lewis, the John Murray Professor of Orthopaedic Oncology, attended Yale University and graduated with a degree in Psychobiology. She then matriculated at Harvard Medical School, graduating with honors. Dr. Lewis completed her Orthopaedic training at the Harvard Combined Orthopaedic Residency Program in Boston, MA and her fellowship in Musculoskeletal Oncology at the University of Chicago.
In 2000, Dr. Lewis joined The University of Texas, MD Anderson Cancer Center. She matriculated through the ranks and in 2010, she was named the Dr. John Murray Professor in Orthopaedic Oncology at the MD Anderson Cancer Center. Currently, and for the past twelve years, Dr. Lewis serves as Director of the Musculoskeletal Oncology Fellowship Program at UTMDACC. In 2012, she was the first African America woman to be awarded the MD Anderson Faculty Achievement Award in Patient Care. Orthopaedic Oncology became a Department in 2014 and after a national search Dr. Lewis was named the inaugural Chair of Department of Orthopaedic Oncology. As such she became to be the first woman to chair an orthopaedic department at a freestanding cancer center, to chair an orthopaedic department in The University of Texas System, and the first African American woman to Chair an Orthopaedic Surgery Department.
Dr. Lewis is very active nationally and internationally within Orthopaedics and Musculoskeletal Oncology. She is active in the American Academy of Orthopaedic Surgeons (AAOS), American Orthopaedic Association (AOA), the Musculoskeletal Tumor Society (MSTS), and the International Society for Limb Salvage (ISOLS) and the Western Orthopaedic Association (WOA). She served on the board of the American Orthopaedic Association from 2007 to 2010, the board of the Western Orthopaedic Association from 2005 – 2014, the MSTS board from 2017-2020 and the ISOLS board from 2019-2021. In 2014-2015 she served as President of the Western Orthopaedic Association. Dr. Lewis is a strong advocate of education, and as such, served as the Chair of the MSTS Education Committee, Chair of the AAOS Instructional Course Lecture Tumor Subcommittee, Chair of the Musculoskeletal Oncology Content Committee for the AAOS Council on Education and Chair of the ISOLS Education Committee.
Dr. Lewis’ expertise is with treating both children and adults with bone and soft tissue sarcomas of the pelvis and extremities. In 2011 she started the Multidisciplinary Pelvic Sarcoma Program at MD Anderson Cancer Center that not only addresses the clinical needs of this unique group of patients but works to improve both the clinical and functional outcome of patients with pelvic sarcoma. Her research works to investigate the gene functions tied to osteosarcoma and the development of treatments that might interrupt this process.
Married for 26 years, Dr Lewis is the mother of two wonderful 17-year-old twins.

Santiago A. Lozano Calderón serves both, as an Orthopaedic Oncologist in the Department of Orthopaedic Surgery at the Massachusetts General Hospital and as an Instructor in Orthopaedic Surgery at Harvard Medical School. He was born in Bogotá, Colombia. He completed his medical training back home at Pontificia Universidad Javeriana. Subsequently, he received a masters in Clinical Epidemiology from Colegio Mayor de Nuestra Señora del Rosario and Hospital Fundación Santafé de Bogotá in 2003. Dr. Lozano came to the United States in late 2003. As a foreign medical trainee in a very competitive field, the opportunities and mentoring from internationally renowned orthopaedic surgeons such as Jesse Jupiter, David Ring and Mark Vrahas, allowed him to become a research fellow in the orthopaedic hand and upper extremity service at Massachusetts General Hospital. After four productive years in clinical and basic science research, he earned his clinical PhD degree in 2008 from the University of Amsterdam, Academish Medisch Centre, Amsterdam, The Netherlands. He subsequently completed his training in orthopaedic surgery at New York Medical College, Valhalla, NY in 2012. He obtained his degree as a Musculoskeletal Oncologist from the Harvard University Combined Orthopaedic Oncology Fellowship (MGH/BIDMC/CHB) in 2013. He initially worked at these three institutions but transitioned fulltime to MGH this past December.
Dr. Lozano has had a very productive career in musculoskeletal oncology. He has participated in multiple regional, national and international conferences with podium and abstract presentations. He has more than 60 publications in peer reviewed journals and book chapters. A main interest of his academic practice is international collaborations. He has organized and has participated in different musculoskeletal oncology courses in the US, Mexico, Colombia, Panamá and Perú. This international collaboration is materializing in a large musculoskeletal oncology registry for the Latin American Society of Musculoskeletal Tumors (SLATME). He is an active member of the Musculoskeletal Tumor Society (MSTS), the International Society of Limb Salvage (ISOLS), The Connective Tissue Oncology Society (CTOS), La Sociedad LatinoAmericana de Tumores Musculosqueléticos (SLATME), La Sociedad Colombiana de Ortopedia y Traumatología (SCOT), The American Academy of Orthopaedic Surgeons (AAOS), The New England Orthopaedic Society (NEOS) and the Massachusetts Orthopaedic Association (MOA). He is also a candidate member for the European Musculoskeletal Oncology Society (EMSOS).
His research focuses on: oncology of the pelvis and of the upper and lower extremities, cost-effectiveness in the surgical management of metastatic disease with emphasis in renal cell and thyroid carcinomas, nutritional optimization before surgery in patients with primary bone and soft tissue sarcomas, and infections in megaprostheses and their management, among other areas of research.
In addition to his research activities, as an instructor in orthopaedic surgery, he runs different regular conferences including the weekly musculoskeletal oncology residents and fellow’s conferences, as well as the monthly clinical research meeting and Journal Club.

Out of work, he enjoys to spend time with his wife and five children. In a busy household, there is always time for soccer, basketball, hockey and swimming games and practices, with an occasional ice cream or a movie in between. When time allows, he enjoys to play guitar and read Latin American literature. On Thursdays, he is a regular patron at Harvard Gardens or the Liberty Hotel where he always enjoys a beer with friends, colleagues, coworkers, fellows and residents in service.

R. Lor Randall, MD, FACS, is the Chair of the Department of Orthopaedic Surgery at the University of California, Davis in Sacramento. Dr. Randall’s clinical practice and research focus on musculoskeletal surgical oncology and on building-leading edge trans-disciplinary teams to combat rare cancers of connective tissue in children and adults. His translational research efforts have been recognized internationally, including his work as chief of the Sarcoma Array Research Consortium (SARC) lab, a laboratory investigating the molecular genetic mechanisms that give rise to sarcomas; his development of a genetically engineered mouse model at the University of Utah (in cooperation with Nobel Prize co-winner Mario Capecchi); and his technical advancements in limb salvage surgery.
Dr. Randall is a professor of Orthopaedic Surgery and holds the David Linn Chair in Orthopaedic Surgery.

Dr. Peter Rose is an orthopedic oncologist in Orthopedic Surgery at Mayo Clinic. He is also division chair of the Orthopedic Oncology division of the department

Dr. Howard Rosenthal serves as the Medical Director of the Sarcoma Center at the University of Kansas Health Systems. Completing his fellowship in Orthopedic Oncology at Memorial Sloan-Kettering Cancer Center, his practice, both in the Academic as well as private practice arenas have enabled him to develop a practice and curriculum allowing for the upmost care of his patients and education of his students for over 30 years. He serves as a mentor and leader in the practice of Musculoskeletal Oncology. He is board certified by the American Board of Orthopaedic Surgery and a fellow in the American Academy of Orthopaedic Surgery. He is a member of MSTS, ISOLS, and CTOS and serves in various committees in all.

Pietro Ruggieri is Chairman of the Department of Orthopedics and Orthopedic Oncology and Director of the Scientific Center for Research of Musculoskeletal Tumors "Mario Mercuri", University of Padova. He is President of EMSOS. Past President and Secretary General of ISOLS. Scientific Coordinator for EFORT and Vice Chair of the Education Committee of EFORT (EOTEP). Chair of the Infections Committee of SICOT. His main fields of research are musculoskeletal oncology, reconstructive surgery and prostheses in musculoskeletal oncology.

Florencio Segura, MD, PhD, Oncologic Orthopaedic Surgeon, Professor, Orthopaedic Department, Chief, Cordoba Sarcoma Unit, Director, Centro Privado Ortopedia y Traumatología, Universidad Nacional de Córdoba, Ciudad de Córdoba, República Argentina

Senior consultant orthopedic oncology and limb salvage surgery
Head of orthopedic oncology unit
Director of medical education.

Dr. Michiro Susa is an orthopaedic surgeon who specializes in oncology from Japan. Has been selected as one of the Best Doctors in Japan since 2016 (Best Doctors, Inc), Dr. Susa specializes in both surgery and chemotherapy. He holds a medical and PhD degree from Keio University of Japan, and has been a postdoctoral fellow at General Hospital Vienna and research fellow at Massachusetts General Hospital.

Michiel van de Sande currently works as a Professor of (paediatric) Orthopedic Surgery at the Leiden University Medical Center (LUMC) and the Princes Maxima Center for paediatric oncology in Utrecht where he surgically treats paediatric, AYA and adult patients with bone and soft tissue tumors. He started in Leiden in 2010 as an Senior Orthopedic Surgeon, immediately after completing his Orthopedic training that was followed by a fellowship in paediatric Orthopedic oncology at the Nuffield Orthopedic Center in Oxford. His surgical Specialty focusses on the treatment of pediatric, AYA and adult patients with Bone and soft tissue sarcomas (pelvic and limb reconstruction).

His scientific activity started with the design of (inter)national sarcoma databases and registrations. Under his clinical lead, the LUMC sarcoma Biobank was linked to the LUMC Sarcoma database. Research lines have been set up in recent years which have an international collaborative basis, such as multicenter studies on giant cell tumors of the joint and bone, soft tissue sarcomas, chondrosarcomas, adamantinoma, Osteo- and Ewing Sarcoma.

He has published more than 160 peer reviewed papers and book-chapters; His research was funded by several scientific grants; e.g. the Dutch Cancer Fund (KWF), Alpe-D’huzes. He is appointed as a full professor of orthopedic oncology May first 2020 at the department of Orthopedics at the LUMC.

Professor Oleg Vyrva, MD, PhD, MBA, was born in 1966 in the former Soviet Union and received his Medical Degree with honors in the Kharkiv National Medical University, Ukraine in 1989. He completed a residency in orthopedic surgery and received a PhD degree in Kharkiv Postgraduate Medical Academy in 1997. From 1997 till now Oleg Vyrva takes the position of a Chief Medical Officer at the Sytenko Institute of Spine and Joint Pathology, Kharkiv, Ukraine, specializing in the most complex fields of orthopedics and trauma. Following a Modular Universal Tumor and Revision System Course in orthopedic oncology and reconstruction by Prof. W. Winkelmann in University Clinic of Munster, Germany in 2000 Oleg Vyrva founded and headed a first Bone Tumor department in Ukraine.

In 2005 he has successfully graduated a clinical fellowship for Adult Joint Reconstructive Surgery in Deaconess Hospital of Cincinnati, OH, USA. In 2007 Dr. Oleg Vyrva competed a course on Musculo-Skeletal Pathology at Rizzoli Orthopaedic Institute of Bologna, Italy. Following year, he attended a clinical fellowship in Total Knee and Hip Replacement at Wellington Orthopaedics and Sports Medicine Hospital of Cincinnati, OH, USA. In 2010 he participated in a fellowship for Adult Reconstructive Surgery of the Hip and Knee at Samaritan Hospital Orthopaedic Center of Excellence in Cincinnati, OH, USA.

Pursuing an academic career, Oleg Vyrva earned a professor degree in orthopedics, trauma, and bone oncology at National Ukrainian Medical Academy in 2011. His publication record includes over 350 peer-reviewed articles in the national and international specialty journals. He has been a speaker and moderator at numerous orthopaedic meetings and a faculty member of many practice courses. He is a member of several orthopedic and oncology societies, such as ISOLS, EMSOS, SICOT, AAOS, EFORT. He has been a Board Member of the EMSOS for many years. Professor Vyrva is successfully mentoring residents and fellows as a part of his academic work. He is also an Editorial Board Member and reviewer for several specialty journals in Ukraine.

In his clinical practice, Prof. Vyrva specializes in total hip and total knee arthroplasty as well as the orthopaedic trauma and bone oncology. His expertise covers failed and infected total joint cases management, as well as complex joint reconstruction following trauma. He is a leading consultant in trauma, orthopaedics, and orthopaedic oncology in Ukraine, performing adult and pediatric bone and soft tissue tumor surgeries, complex reconstructions, including limb salvage procedures. Oleg Vyrva handles several hundred surgeries per year (over 12000 cases in total) taking challenging cases that others refuse to perform.

Professor Oleg Vyrva currently takes a position as a Vice-President of the National Ukrainian Orthopaedic Trauma Association.

Professor Wafa is head of clinic in orthopaedic oncology and knee surgery in Leuven University Hospitals, Belgium. He was qualified in Egypt in 1997, obtaining his PhD in Orthopaedic Oncology in 2008 and the Fellowship of the Royal College of Surgeons of Edinburgh in Trauma and Orthopaedic Surgery in 2013. He has completed orthopaedic oncology and lower limb arthroplasty fellowships at the world renowned units in Birmingham and Bologna. He worked as a Consultant Orthopaedic Surgeon at the Royal Orthopaedic Hospital in Birmingham and Glasgow Royal Infirmary before moving to Belgium in 2017. His research work includes work on rotationplasty, endoprosthetic reconstructions in children and silver coating of megaprostheses. He is a reviewer for multiple leading orthopaedic journals. He has specialist interest in orthopaedic oncology, complex and revision knee and hip arthroplasty, and the management of periprosthetic joint infections.

. Born 1965
. Graduated faculty of medicine, Cairo university 1988
. Orthopaedic residency at Cairo university hospitals 1989-1992
. Orthopaedic oncology fellowship at Massachusetts General hospital, Boston, USA 1993/1994
. PHD orthopaedics 1997 (thesis on establishment of a bone bank and use of allografts)
. Director of Cairo university bone bank 2016-2020
. Head of orthopaedic oncology unit, Cairo university since 2010

Reinhard Windhager received his MD from the University of Innsbruck in 1981 and the Orthopedical Residency Training at the Medical University of Vienna (1984-1988). From 1991 he was appointed head of the Tumour Service at the Department of Orthopaedic Surgery at the Univiersity of Vienna, and held this position until he has been appointed Professor and Chairman of the Department of Orthopaedic Surgery at the University of Graz in 1997.

After rapid extension of the Department and establishment of an Orthopaedic Oncology Service he established and became Head of the University Clinic of Orthopaedic Surgery at the Medical University of Graz in 2001. In 2010 he was elected Chairman of the Department of Orthopaedic Surgery at the University of Vienna, following his teacher Rainer Kotz, and in 2018 after fusion of Orthopaedics und Trauma Surgery he has been appointed Head of this new Department of Orthopaedics and Trauma Surgery at the Medical University of Vienna.

Besides decades of academic leadership Reinhard Windhager headed the Orthopaedic Oncology Service over almost 30 years with innovative contributions in growing prostheses and pelvic resection and reconstruction. In 2013 he established, and since then coordinates the Musculoskeletal Tumour Unit of the Comprehensive Cancer Center at the Medical University of Vienna. He served as ISOLS Treasurer for several years with distinct contribution to the establishment of new bylaws according to Austrian rule and served as President for ISOLS from 2014 to 2015. He furthermore, served as President of the Central European Orthopaedic Congress, the Austrian Society of Orthopaedics and Orthopaedic Surgery and the Austrian Society of Surgeons, as well as the Austrian Musculoskeletal Oncology Society. Furthermore, he organized the EMSOS Congress in Vienna in 2014.

His areas of expertise are Orthopaedic Oncology and Adult Reconstruction, especially Hip and Knee Arthroplasty. He has published more than 450 articles in peer reviewed journals and acts as reviewer to 23 international journals

Dr. Rosanna Wustrack is the Chief of Orthopedic Oncology and an orthopedic surgeon who specializes in the surgical diagnosis and treatment of musculoskeletal tumors and fragility fractures. Dr. Wustrack received an undergraduate degree from Yale University before earning a medical degree from Washington University School of Medicine in St. Louis. She completed an internship and residency in orthopedic surgery at UCSF. Subsequently, she completed fellowship training in musculoskeletal oncology at Memorial Sloan Kettering Cancer Center in New York.

Orthopaedic Surgeon from Pontificia Universidad Católica de Chile with fellowships in Lower Limb Reconstructive Surgery at the University of British Columbia and Musculoskeletal Oncology at the BC Cancer Agency. Member of ISOLS and SLATME (Latinamerican Musculoskeletal Tumor Society). Secretary of the Chilean Society of Orthopaedic Oncology.

Dr. Erik N. Zeegen is a board-certified orthopaedic surgeon who specializes in joint replacement surgery and has extensive experience in anterior hip replacement surgery, less invasive knee replacement surgery, robotic-assisted knee replacement surgery, and complex revision surgery of hip and knee replacements that have failed. Dr. Zeegen is the Chief of Joint Replacement Surgery at UCLA.

He earned his Doctor of Medicine from UCLA in 1996. He also completed his general surgery internship and orthopaedic surgery residency at UCLA. Dr. Zeegen moved to Boston in 2001 and completed a fellowship in Orthopaedic Surgical Oncology at Massachusetts General Hospital and Boston Children's Hospital. He then completed a fellowship in Adult Reconstructive Surgery at Boston's New England Baptist Hospital from 2002-2003 before returning to Los Angeles in late 2003. From 2003 – 2005, Dr. Zeegen was an Assistant Professor of Orthopaedic Surgery at UCLA, and then was the Associate Medical Director of the Valley Hip & Knee Institute in Tarzana, CA until recently being named Chief of Joint Replacement Surgery at UCLA.

Dr. Zeegen is a member of the American Association of Hip and Knee Surgeons, the American Academy of Orthopaedic Surgeons, the California Orthopaedic Association and the American Medical Association. He has authored many academic papers and textbook chapters and lectures on the topic of hip and knee replacement surgery and is a reviewer for several peers reviewed journals. Dr. Zeegen is an Associate Clinical Professor of Orthopaedic Surgery in the Department of Orthopaedic Surgery, David Geffen School of Medicine at UCLA.

Dr. Hornicek is an outstanding clinician‐scientist and educator. A world famous orthopaedic oncologist, Dr. Hornicek is the Chairman of the Department of Orthopaedic Surgery at the University of California, Los Angeles. Dr. Hornicek's clinical research interests include heterotopic ossification, allograph transplantation, immunotherapy, and outcome research for musculoskeletal tumors. Since the 1980s he has been instrumental in improving quality and safety for Tissue Banking globally. He is a world expert on chordoma who works actively with the Chordoma Foundation, established The Stephan L. Harris Chordoma Center at MGH, and brings this expertise as a focus of his activities at UCLA. Dr. Hornicek's basic research efforts have focused on specific aspects of cell biology and more recently, molecular biology of sarcomas. Dr. Hornicek has also focused on the development of new chemotherapeutic drugs isolated from marine organisms for the treatment of sarcomas. This has led to clinical trials and patent applications, and the work has been consistently funded by the NIH, charitable foundations, and industry. Dr. Hornicek has provided mentorship to many clinical trainees and research fellows. Dr. Hornicek graduated with a B.A. in biology and mathematics from Washington and Jefferson College. He earned his PhD in physics‐biophysics from Georgetown University and his M.D. from the University of Pittsburgh. Dr. Hornicek completed his Orthopaedic Surgical Residency at the University of Miami and an Orthopaedic Oncology Fellowship at Massachusetts General Hospital and Children's Hospital Boston. He began his academic career as a faculty member at the University of Miami following his residency and then was recruited to the Harvard faculty in 1998. In 2017, he joined the University of California, Los Angeles as the Professor and Chair.

Professor & Chairman of Orthopaedic Surgery & Traumatology, Athens University School of Medicine
Director, Orthopaedic Research & Education Center "Panayotis N. Soucacos", at Attikon University General Hospital

“Standing on the shoulders of the pioneers of musculoskeletal oncology, ISOLS has been expanded nowadays to the biggest international musculoskeletal tumor and reconstruction association. I am proud to be part of this family.”

- Chief, Orthopaedic Oncology Unit, ATTIKON University General Hospital
- f.A.Consultant & A.Professor, Department of Orthopaedics, Mayo Clinic & Mayo Medical School, Rochester MN, USA
- Clinical fellowship training in Orthopaedic Oncology, Adult Reconstruction and Spine Surgery at the Department of Orhopaedics, Mayo Graduate School of Medicine, Mayo Clinic Rochester MN, USA
- Residency in Orthopedic Surgery, KAT Hospital Athens Greece
- Graduate of Athens University School of Medicine
- Author of more than 350 international publications, 6500 citations and 30 textbook chapters
- H-index 40, i10-index 170 (google scholar)
- Member of many national and international societies including the American College of Surgeons (ACS)
Academy of Orthopaedic Surgeons (AAOS), American Musculoskeletal Tumor Society (MSTS), the International Society for Limb Salvage (ISOLS), the European Musculoskeletal Oncology Society (EMSOS) & the World Society of Reconstructive Microsurgery (WSRM), Hellenic Association Orthopaedic Surgery & Traumatology (HAOST)

As the first dedicated full time Orthopaedic Oncologist in India, he setup the bone & soft tissue service at the Tata Memorial Hospital, Mumbai, the biggest Cancer speciality hospital in India. During the decade that he served there, he pioneered limb salvage surgery in India and also trained several doctors who are now practicing senior orthopaedic oncologists in different parts of the country. In the absence of a formal organ transplantation programme, he pioneered the use of radiated long bone allografts obtained from amputated limbs. He also developed the use of extracorporeal irradiation and reimplantation of bones. He also pioneered the development and use of an indigenously manufactured tumor prosthesis to make the limb salvage affordable. A completely novel hinged tumor knee prosthesis developed by him and the engineers is now under clinical trial at leading sarcoma centres in India. After serving at Tata Memorial for a decade he set up a orthopaedic oncology service at the P D Hinduja Hospital, a reputed private hospital in Mumbai. He now works from the Nanavati Max superspeciality hospital and continues to persue his interest in bioengineering. He has also setup a Sarcoma support group in Mumbai. He has published his work in many reputed journals and has presented at various international and national meetings and is a founding member of the Indian musculoskeletal oncology society. As a member of the education committee of the ISOLS, he has helped continue the teaching program of ISOLS during the pandemic. He is interested in any challenging reconstruction and is actively engaged in setting up a facility for 3D printing implants at a cost that is affordable for the Indian population.

Dr. Benevenia is a graduate of New Jersey Medical School and completed his orthopaedic residency at University Hospital. He completed his fellowship at Case Western Reserve University in Orthopaedic Oncology/Pathology and returned to New Jersey Medical School to continue his career. Since 2005, Dr. Benevenia serves as Professor and Chair in the Department of Orthopaedics at Rutgers, New Jersey Medical School as well as courtesy 0rthopaedic surgeon at Overlook Medical Center, Morristown Medical Center, Barnabas Medical Center and Robert Wood Johnson Medical Center. In his leadership role as Chair, Dr. Benevenia has worked, trained, evaluated, and graduated over 150 Orthopaedic residents and fellows and served as a senior mentor to approximately 25 Orthopaedic faculty members of which 7 were promoted to full title Professors in their respective divisions. Dr. Benevenia’s life long pursuit for clinical excellence is evident in his professional and competent manner and his commitment to integrity, ethical standards and compassionate approach to the delivery of patient care. His subspecialty interests include bone and soft-tissue tumors, allograft and endoprosthetic reconstructions, and limb-salvage surgeries. Specifically, Dr. Benevenia has been a leader in the science and application of allografts and endoprosthetic reconstructions to treat musculoskeletal tumors and has lectured nationally and internationally in his clinical expertise of muculoskeletal oncology and limb salvage.

Örjan Berlin: Born Sept 3, 1948 (emeritus = retired)
MD: Oct 1976, Med School, Univ of Gothenburg
Specialist in Orthopedic Surgery: Oct 1981, Univ of Gothenburg
PhD: April 1988
Thesis: On Leiomyosarcomas of Bone and Venous Origin and The Surgical Treatment of and Prognosis for Extremity Soft Tissue Sarcomas
Assoc Prof: May 1994
Lecture: Lower extremity amputations – old knowledge and new Innovations (osseointegration in the treatment of amputees)
Visiting Professor Dept of Orthopedics, UCSD, CA, USA. 1991 – 1992
Establishment of a Murine Model for Study of Human Osteosarcoma Metastasis

COLLEGE
MEDICAL DEGREE: Médico Cirujano y Partero., Medical School., Universidad Autónoma de Nuevo León UANL, September 1985 – August 1991.

POST GRADUATE STUDIES

• ORTHOPAEDIC RESIDENCY: Orthopaedics, Hospital Universitario. U.A.N.L., “Dr. José E. Gonzalez”, March 1993 February 1997., C.M.O.T. accreditation
• OTHERS: Orthopedic Education in Shoulder., Orthopedic Department. Texas University Health Since, Center. San Antonio Tx., October and November 1996.
• FELLOWSHIP: Oncology Orthopedics, Oncology Orthopedic Department, M.D. Anderson Cancer Center. Houston Tx., Jun – December 1997.

TEACHING

• Associate Professor | Orthopedic department Hospital Universitario UANL. Since January 1998.
• Head of Post Graduate Studies. | Orthopedic Department. Hospital Universitario UANL. 2006 – 2014.
• Head of the Orthopedic Oncology Service. | Orthopedic Department. Hospital Universitario UANL. Since 1999.

SOCIETIES

• Sociedad de Ortopedia y Traumatología de Nuevo León, A.C. | Member since1997.
• Consejo Mexicano de Ortopedia y Traumatología, A.C. (CMOT) | Member since 1997.
• Asociación Mexicana de Ortopedia y Traumatología, A.C. (AMOT) | Member since 1997.
• Sociedad Mexicana de Ortopedia y Traumatología (SMO) | Member since 2007
• Sociedad Latinoamericana de Tumores Musculoesqueléticos (SLATME) | Member since 2004
• International Society of Limb Salvage (ISOLS) |First Mexican member | Member since 2007

SOCIETIES CHARGES

• SLATME President.| Latin American Society of Musculoskeletal Tumors | 2008 -2010.
• Founder Member of the Mexican Society of Musculoskeletal Tumors and Limb Salvage. SMOOSE.| 1rst SMOOSE President. 2009-2019.

Dr. Crawford is an orthopaedic oncologist in the Department of Orthopaedics at the University of Miami Hospital. She completed her oncology fellowship in 2016 at the Harvard Combined Fellowship between Massachusetts General, Beth Israel Deaconess and Boston Children’s Hospitals. She started her practice at City of Hope Cancer Center in Southern California, and was recruited to UCLA and then to Miami by her mentor, Dr. Fran Hornicek. She is a member of the Musculoskeletal Tumor Society, the Vice President of the Musculoskeletal Oncology Research Initiative, and a fellow of the American Academy of Orthopaedic Surgeons. Her main research focus involves a collaboration with California Institute of Technology to develop their photoacoustic laser technology into a clinical imaging modality for calcified bone specimens.

Christina D’Anjou is a Director of Product Development at Stryker. She has worked as an engineer and leader in the medical device industry for 15 years, and has dedicated much of her career to developing products for orthopedic oncology and revision surgery. She received her undergraduate degree in Biomedical Engineering from Rensselaer Polytechnic Institute and her Masters in Business Administration from Pennsylvania State University. She looks forward to collaboration with clinicians and researchers from around the world at ISOLS 2022 and beyond.

Dr. Dickey is an Orthopaedic Oncologist. He did his undergraduate and medical school at the University of British Columbia, and then completed his internship and residency in Orthopaedics at McGill University, followed by a fellowship with two years of Adult Reconstruction and Musculoskeletal Oncology at the Mayo Clinic in Rochester, MN.
He is an adjunct professor in Biomedical Engineering as well as External Faculty of the Graduate School at the University of Maine, where he also received an honorary Francis Crowe degree in 2006. He maintains a collaborative laboratory looking at in-vitro and in-vivo models of tissue attachment in additive manufactured highly porous foams.
Dr. Dickey is the chair of the EAB for the Biomedical Engineering Undergraduate program at the University of Maine. He is also a review member of the Musculotskeletal Tumor Society Research Committee. In addition, he is the current president of the Franklin Hindson Sim Tumor Society.
Dr. Dickey is active in industry & research collaboration, working in a research and consultancy role with Wright Medical, Conformis Inc., Stryker, Angiotech, Ferring, Zimmer and Sanofi-Aventis. He currently participates in the Stryker Tritanium Shell Study and the Conformis Inc. CR and PS CT/3D Printed TKR Studies.
Dr. Dickey founded and runs the Chords for Cure initiative to raise funds to help children with cancer, currently in its 15th year with over $250,000 raised to date.
Originally from Vancouver, BC, he is now practicing in Denver, Colorado as an Assistant Professor with the University of Colorado Department of Orthopaedics and the Eastern Colorado Veterans Administration

Matthew T. Houdek, MD is an Associate Professor of Orthopedic Surgery and the Fellowship Director for Musculoskeletal Oncology at the Mayo Clinic. He received his MD from the University of Arizona. He went on to be trained in Orthopedic Surgery at Mayo Clinic, and then fellowship in Musculoskeletal Oncology at the University Musculoskeletal Oncology Unit at Mount Sinai Hospital and University of Toronto. Dr. Houdek is an orthopedic oncologist treating both children and adults with bone and soft-tissue sarcomas of the pelvis and extremities. Dr. Houdeks’ clinical and research interest include outcomes of complex reconstruction and limb salvage, with a focus on upper extremity sarcomas.

Professor Jeys is one Royal Orthopaedic Hospital, which is one of only five purely orthopaedic hospitals in the country, covering a population of 22 million people for sarcoma referrals. He has an international reputation for Sarcoma Surgery and Complex Revision Arthroplasty. He is particularly well known for Pelvic Sarcoma surgery including the advances in computer navigated surgery and 3D printed implants.
He has published over 300 scientific papers including 196 medline referenced articles. Professor Jeys was recently awarded the DSc for his thesis 'Improving Patient Outcomes by Innovation and Collaboration'. The DSc is the highest research degree in the UK and only awarded for individuals who make an outstanding contribution to their field. Professor Jeys regularly lectures around the world on joint replacement and tumour surgery.
He is involved with several national committees including being the former Chairman of the National Centre Research Institute (NCRI) for Sarcomas. He is a Board Member of EMSOS. He has worked with NICE, health technology appraisal boards, as well as several multinational companies.

Qualified Medical Doctor from Athens University in 1982, registered Orthopaedic Surgeon - Greece and UK - in 1992, PhD at Medical School of Athens University in 1992.
Served in Greek Navy 1982-1984, Surgical Resident in Kalamata General Hospital and Orthopaedic Resident at Athens University between 1985-1991. Further training at Glan Clwyd Hospital, Rhyl, N. Wales-UK and Sunnybrook Health Science Center, Toronto-Canada in 1992.
Training in Bone and Soft Tissue Tumour Orthopaedic Surgery at Royal National Orthopaedic Hospital, Stanmore, London-UK from 1992 -1993 and 2002-2004.
NHS Consultant Orthopaedic Surgeon from 1995 at Kalamata General Hospital and St Savvas Oncologic Hospital in Athens since 2000.
Head of Orthopaedic Oncology Department since 2008, President of the Scientific and Ethical Committee 2013-2017, Medical Director of St Savvas Hospital since 2018.
President of the Hellenic Association of Orthopaedic Surgery and Traumatology in 2021.
Active member of several professional bodies, participated and organised numerous Orthopaedic Meetings, presented and published plethora of papers, provided significant amount of mentoring, training and educational lecturing throughout his career.
Vast experience in Orthopaedics undertaking surgery for every type of bone and soft tissue tumours as well as trauma and complex adult joint reconstruction.

Education and work history

• 1981 - 1987 | Okayama University Medical School 
• 1987 - 1991 | Okayama University Graduate School of Medicine
• 1996 - 1999 | Assistant Professor, Okayama University Hospital
• 1999 - 2002 | Researcher, Münster University   
• 2002 | Habilitation in Münster University
• 2002 - 2005 | Senior Lecturer, Okayama University Hospital
• 2005 - Present | Professor and Chairman, Department of Orythopaedic Surgery, Okayama University
  Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences

Major committee assignments

• 2008 -    Asia-Pacific Musculoskeletal Tumor Society (board member)
• 2013 -    International Society of Limb Salvage (board member)
• 2013 -    Japan Ewing Sarcoma Study, JESS (chairperson)
• 2017 -    Japan Clinical Oncology Group, JCOG (chairperson of bone and soft tissue tumor study group)

Jonathan C. Trent, MD, PhD, focuses his clinical, educational, and research efforts on GIST, chondrosarcoma, and other sarcomas. His interests include the clinical and translational research of sarcomas, the direct care of patients with sarcoma, and education about sarcoma and patient-oriented research. As Associate Director for Clinical Research, his goal is to help Sylvester faculty develop clinical trials that provide clinically effective and scientifically exciting therapy to patients with cancer. The major efforts of Dr Trent’s research focus on understanding the mechanisms of action and resistance of imatinib in GIST and other sarcomas while striving toward improved therapeutic options. His work involves the use of novel preoperative/postoperative clinical trials, prospectively acquired tumor tissue, cell lines, and archival tissue.

Franklin H. Sim was born in Halifax, Nova Scotia, Canada, and graduated from Dalhousie University Medical School in 1964. He completed his orthopedic residency training at Mayo Clinic, and received his Master of Orthopedic Surgery from the University of Minnesota. He joined the orthopedic staff of Mayo Clinic in 1970 and became a leading innovator and proponent of limb sparing surgery in patients with bone and soft tissue tumors. He was a founding member of the Musculoskeletal Tumor Society(MSTS) as well as the International Society of Limb Salvage (ISOLS) and has been active in the International Skeletal Society (ISS). He is a member of numerous medical societies including the American Academy of Orthopedic Surgeons (AAOS), the American Orthopedic Association (AOA), and the Canadian Orthopedic Association (COA). During Doctor Sim’s 48-year career on the Mayo Clinic faculty he has trained hundreds of residents and more than 60 orthopedic oncology fellows from the United States and overseas.

His research and clinical interests have centered on the outcomes of complex limb and pelvic reconstruction for tumor resection and work in the areas of complex hip and knee replacement. He has authored many of the seminal papers in the field of musculoskeletal oncology. His prolific publication record includes almost 500 published articles and 200 book chapters. Over the course of his career, Doctor Sim has received many prestigious awards including the John Charnley Award of the Hip Society, the Canadian Orthopedic Association Outstanding Service Award, the Distinguished Mayo Clinician Award, the Dalhousie Alumnus of the Year Award, the AOA Distinguished Contributions to Orthopaedics Award, and the American Academy of Orthopedic Surgeons Diversity Award. Currently he is an Emeritus Professor of Orthopedic Surgery and emeritus chair of the Division of Orthopaedic Oncology at Mayo Clinic in Rochester, Minnesota.

Peter Steadman is a Professor of Orthopaedic surgery at the University of Queensland in Brisbane Australia.
He has been in orthopaedic oncology practice since 1996.He is an ISOLS board member and Chairperson of the ISOLS international education committee and coordinated monthly seminars online through the Covid-19 period along with the education board members. He is the host of the next ISOLS meeting in Brisbane in October 2024

Cat is currently a plastic surgery registrar on the London training programme. She completed medical school at the University of Birmingham, UK, in addition to obtaining a bachelor’s degree in the history of medicine conducted between the Birmingham and Columbia Presbyterian, New York. She held an academic foundation doctor position in a major trauma centre, prior to a year’s junior fellowship in sarcoma. She completed her basic surgical training in both orthopaedics and plastic surgery within the London deanery prior to commencing residency. Her academic interests lie in limb reconstruction following both sarcoma and trauma. Cat has been a member of ISOLS for many years and is thrilled to be part of the Young Surgeon’s initiative.

Ege University School of Medicine
Dept of Orthopedics and Traumatology

Vice Editor Acta Orthopecia Turcica
Referee of Journal of Orthopedics and Traumatology
Former President of Turkish Musculoskletal Tumor society
Former President of Asia Pacific Musculuskeletal Society
Former Scientific Committee Member or SICOT, EFORT,EMSOS,APMSTS

Dr. Evanthia Galanis is a Professor of Oncology and Sandra J. Schulze Professor of Novel Therapeutics at the Mayo Clinic where she has served as the Chair of the Department of Molecular Medicine and leader of the Virus and Gene Therapy Program of the Mayo Clinic Comprehensive Cancer Center. She currently serves as the Mayo Clinic Executive Dean of Development. Dr. Galanis’ laboratory research focuses on the development and optimization of novel virotherapy and immunovirotherapy approaches in the treatment of cancer with special focus on sarcoma, glioma, breast and ovarian cancer. Her laboratory is testing a number of different strategies including use of therapeutic genes and payloads; trackable markers; combinations with small molecules, cytotoxic agents and radiation therapy; retargeting of viral strains against tumor specific antigens and tumor stem cells; novel viral delivery approaches such as cell mediated delivery into tumor targets; and immunomodulatory strategies in order to increase the immunostimulatory potential of oncolytic cell death and reverse immunosuppression. A significant impetus for her research has been the translation of laboratory advances into clinical trials of novel therapeutics for cancer patients. She has served as principal investigator in multiple phase I/II cancer gene therapy and virotherapy trials and has pioneered the clinical testing of oncolytic virus derivatives or oncolytic virus infected adipose tissue derived mesenchymal stem cells in patients with recurrent glioma, ovarian and breast cancer.

Krista Goulding, MD received her BS with Honours and her medical degree from McMaster University in Hamilton, Ontario, Canada. She had a Residency in Orthopaedic Surgery and Musculoskeletal Oncology both through the University of Ottawa, Ottawa, Ontario, Canada. Dr. Goulding had another Musculoskeletal Oncology Fellowship from the Royal Orthopaedic Hospital, Birmingham, United Kingdom. She received her Masters in Public Health from Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Dr. Goulding also had a Fellowship in Adult Reconstructive Arthroplasty/Musculoskeletal Oncology at the Mayo Clinic Graduate School of Medicine.

Dr. Goulding was an Active Member of McGill University Health Center and an Associate Investigator of the Cancer Research Program and Injury, Repair & Recovery Research Program. She was Associate Member of LaSalle General Hospital Orthopaedic Surgery and Ambulatory Surgery.

Krista is a Consultant in the Department of Orthopedic Surgery, Mayo Clinic, Phoenix, Arizona and has an academic rank of Assistant Professor of Orthopedics through the Mayo Clinic College of Medicine and Science.

Dr. Goulding has presented at numerous National and International Conferences and has participated in 3 Visiting Professorships. She has thirty peer-reviewed publications and 2 book chapters.

Ivan Tornos joined Zimmer Biomet in November 2018 as Group President, Orthopedics, and a year later was named Group President, Global Businesses and the Americas. He was appointed as Chief Operating Officer in March 2021. In addition to his continued leadership of the Americas region, Mr. Tornos also oversees the Europe, Middle East and Africa (EMEA) region.
Prior to joining Zimmer Biomet, Mr. Tornos served as Worldwide President of the Global Urology, Medical and Critical Care Division of Becton, Dickinson and Company. Prior to that, he was with C.R. Bard in positions of increasing responsibility, most recently serving as President, Europe, Middle East and Africa Regions. Before joining C.R. Bard, Mr. Tornos served as Vice President and General Manager of the Americas Pharmaceutical and Medical/Imaging segments of Covidien International. Before that, Mr. Tornos served as International Vice President, Business Development and Strategy with Baxter International Inc. and prior to that, he spent over a decade in leadership assignments around the globe with Johnson & Johnson.
Mr. Tornos is an alumnus of the Harvard Business School, having graduated from the Advanced Management Program and also completed leadership and management programs at the Cox School of Business of Southern Methodist University. He finalized post-MBA work at the Wharton School of the University of Pennsylvania (CPD Marketing/Finance), holds an MBA from the University of Miami School of Business and a BBA in Finance and International Marketing and Management from the University of Georgia Terry College of Business. Mr. Tornos currently serves as an independent external director on the Board of Directors of PHC Holdings Corporation.

Dr. Douglas Letson is Executive Vice President of Clinical Affairs and Physician-in-Chief at Moffitt Cancer Center in Tampa, FL.
Prior to his current position, Dr. Letson served as the Chair of the Sarcoma Department at Moffitt. He is a professor of Surgery, Radiology and Orthopedics at the University of South Florida.
Dr. Letson received his medical degree and completed an orthopedic residency at Louisiana State University in New Orleans. He also completed a fellowship in Musculoskeletal Tumor Surgery at Harvard Medical School in Boston. He has extensive clinical experience in the areas of pediatric and adult limb salvage in both bone and soft tissue tumors. His clinical interests have a strong scientific focus in the development of tumor prosthesis.
Dr. Letson has a reputation as a leader in medical education, and he lectures nationally and internationally on this topic. He has started multiple educational courses world wide in medical education and leads a course at the University of Oxford. He is an active member of the American Academy of Orthopedic Surgeons (AAOS), the American Orthopedic Association (AOA), the Musculoskeletal Tumor Society (MTST), the Connective Tissue Oncology Society (CTOS), the Children’s Oncology Group (COG), and the International Society of Limb Salvage (ISOLS). Dr. Letson has served on the editorial board of several orthopaedic journals, including the Journal of the National Comprehensive Cancer Network and the Cancer Control Journal.

Dr. Mishil Parikh is a practicing Musculoskeletal Oncologist in Mumbai and Navi Mumbai. Following his post-graduation, he was trained at The Tata Memorial Cancer Hospital, Mumbai, for three years where he gained extensive experience and skill in the management of Bone and Soft Tissue Tumors. He also holds a Short-Fellowship from the University of Florida, USA. He is the youngest Musculoskeletal Oncologist in the country.
He specializes in the management of all Malignant and Benign, Musculoskeletal Tumors and Skeletal Metastases. He is well versed with Limb Salvage techniques with the use of Implants, Megaprosthesis and Biological Methods.

Education

• 2003-2007. Basic science. Assistant of Anatomic Department of Republic University (UdelaR) –School of Medicine.
• 2007: Medical Doctor, graduated from Republic University (UdelaR) – school of Medicine.
• 2012: Postgraduated Course of Orthopedic Surgery, Republic University (UdelaR) –school of Medicine.
• 2013: Interine assistant orthopaedics and trauma clinic. Republic University (UdelaR) – Montevideo Uruguay.
• 2014: Titular assistant orthopaedics and trauma clinic Republic University (UdelaR) – Montevideo Uruguay.
• 2021: Titular Adj. Prof. orthopaedics and trauma clinic. Republic University (UdelaR) – Montevideo Uruguay.

FELLOWSHIPS OR STUDY ABROAD：

• 2015. Fellow Orthopaedic Oncology . Santa Casa of Porto Alegre Brasil.
• 2016. Fellow Orthopaedic Oncology. Santa Casa of San Pablo Brasil.
• 2017. Fellow Orthopaedic Oncology. Kanazawa University . Japon.

MEMBERSHIPS：

• SLATME. Latin American society of Musculoskeletal tumor
• SOTU. Uruguayan Society of Orthopaedic and Trauma
• SLAOT. Latin American society of Orthopaedic and Trauma
• ISOLS. International society of limb salvage.

Dr. Scarborough is a professor and Department Chair at the University of Florida Department of Orthopaedics & Sports Medicine. He completed his Orthopedic Oncology Fellowship at Massachusetts General and Boston Children’s Hospitals in 1991, under the mentorship of Drs. Mankin, Springfield and Gebhardt. He has been on faculty as an Orthopedic Oncologist at the University of Florida since 1991. He is a member of the American Musculoskeletal Tumor Society and ISOLS. He is a past president of ISOLS and helped lead the ISOLS meeting in Orlando in 2015. He is an active educator having served on the faculty of the University of Florida Musculoskeletal Pathology Seminar (the Enneking Path Course) since 1991.

Dr. Siegel received his MD degree from New York University (NYU) School of Medicine. He completed an orthopedic surgery residency at the University of Southern California (USC), Los Angeles, and an orthopedic oncology fellowship at the Mayo Clinic, Rochester, Minnesota. He joined the UAB faculty in 2002 and since has developed one of the busiest complex revision joint practices in the Southeast. He has a special interest in the advancement and development of joint replacement implants and instrumentation.

• 12/2003-12/2009 | Resident, Department of Orthopedics, University Hospital Mϋnster, Director Prof. Dr. W. Winkelmann
• 01/2007 bis 01/2008 | Resident, Trauma Department, University Hospital Mϋnster, Director Prof. Dr. Μ. Raschke
• 12/2009 | Specialist in Orthopedics
• 10/2012 | Consultant surgeon, Department of Orthopedics and Surgical Oncology, Specialized in Surgical Oncology, Revision Surgery, Septic Surgery
• 2/2014 | Veniα legendi for Orthopedics, Medical Faculty University of Mϋnster
• 7/2016 | Deputy Director, Department of Orthopedics, University Hospital Mϋnster
• 10/2016 | Associated Professor, Medical Faculty, Uniνersity of Mϋnster
• since 4/2018 | Director, Department of Tumourorthopedics and Sarcoma surgery, Uniνersity Hospital of Essen, Germany

School Education

• 08/71-07/75 Gemeinschafts-Grundschule Hasenberg, Remscheid (primary school)
• 09/75-07/81 Stadtisches Rontgen-Gymnasium, Remscheid-Lennep (grammar school)
• 09/81-05/84 Stadt. Engelbert-von-Berg Gymnasium, Wipperfϋrth (grammar school)-Examination: A-level

Military Service

• 09/84-12/85 Staff Soldier at Materialamt der Luftwaffe' Koln-Wahn, Rank: Obergefreiter (Lance Corporal)

Study

• 01 /86-07 /86 lnternships:
  - Rhewum GmbH' Remscheid, (mechanical engineering company)
  - technical department of the Krankenanstalten Remscheid,
• 09/86- 08/92 Study of Biomedical Engineering
  - Fachhochschule Hamburg', (Technical University, Hamburg) Degree: Dipl.-lng. Biomedizinische Technik (Biomedical Engineer)

Diploma Thesis

• 09/92-05/93 "Fourier-transformed infrared spectroscopy as an ίn-νίνο method to measure the water content of the human skin" Experimentelle Dermatologie, Paul Gerson Unna-
  - Forschungszentrum, Dermatologica Research Center, Beiersdorf AG, Hamburg, Germany

Career Details

• 08/93-01 /94 Sales Representative for Orthopaedic and Traumatologic Devices
• 02/94-09/94 Junior Product Manager Total Knee Systems
• 10/94-12/95 Product Manager Total Knee Systems
• 01/96-03/01 Senior Product Manager Total Knee - and Total Shoulder Systems - Smith & Nephew, Schenefeld, Germany
• 04/01-today Director Marketing and Sales, -implantcast GmbH, Buxtehude, Germany

Knowledge of Foreign Languages - English: fluenty - French: basics - Spanish: a little

Han-Soo Kim, M.D., Ph.D - ISOLS Board Member

Giovanni Paraliticci, M.D., is a fellowship-trained, board eligible Orthopedic Surgeon. Dr. Paraliticci completed his medical degree, General Surgery Internship, and an Orthopedic Surgery Residency at the University of Puerto Rico. He completed a Musculoskeletal Oncology Fellowship at the University of Miami and an Adult Hip & Knee Reconstruction Fellowship at the Miami Orthopedics & Sports Medicine Institute.
Dr. Paraliticci specializes in orthopedic surgical oncology at the Miami Cancer Institute and is an Orthopedic Surgeon with the Miami Orthopedics & Sports Medicine Institute. His specialization extends to surgical treatment of musculoskeletal tumors, soft tissue tumors, and metastatic lesions. He also treats oncologic patients with orthopedic problems including fractures, arthritis, avascular necrosis, and osteoporosis.
Dr. Paraliticci has extensive training and experience in surgical management of arthritic conditions of the hip and knee. He is skilled in procedures including primary and revision total knee and hip arthroplasty, partial knee arthroplasty, custom knee replacements, and robotics. Dr. Paraliticci’s goal is to maximize the function of each patient with advanced surgical and reconstructive techniques.

Education & Training

• Miami Orthopedics & Sports Medicine Institute - Fellowship Program, Adult Hip & Knee Reconstruction, 2019
• University of Miami/Jackson Memorial Hospital - Fellowship Program, Musculoskeletal Oncology, 2018
• University of Puerto Rico - Residency Program, Orthopaedic Surgery, 2017
• University of Puerto Rico Medical Sciences Campus - Internship, General Surgery, 2012
• University of Puerto Rico School of Medicine (San Juan) - Medical School, MD, 2010

Dr. Yechieli is an Associate Professor in Radiation Oncology at the University of Miami and Medical Director for the department of Radiation Oncology at Jackson Memorial Hospital. He specializes in treating patients with sarcoma, lung cancers, brain metastases, genitourinary tumors and keloids. He has experience and expertise in the use of multiple treatment techniques including Proton therapy, Stereotactic Radiation, Gamma-Knife Radiosurgery and MR-Guided radiation therapy. His research interests are in delivery and outcomes for cancer patients, with a focus on patient-centered care, and education of the next-generation of radiation oncologists. He received his undergraduate degree from Ner Israel Rabbinical College in Baltimore graduated medical school from University of Maryland, Baltimore. He completed his residency in Radiation Oncology at Henry Ford Hospital in Detroit MI, where he served as Chief Resident from 2013-14. Dr. Yechieli is the co-leader of the thoracic site disease group at Sylvester Comprehensive Cancer Center and serves on multiple local and national leadership committees and organizations.

Per Rickard Braanemark, MD, PhD, presently Research Scientist at the Biomechatronics Group at MIT Media Lab, Cambridge, MA, Associate Professor at the Department of Orthopaedics, Gothenburg University, Gothenburg, Sweden, Professor Emeritus at the Department of Orthopaedics, University of California, San Francisco, CA, CEO and Founder of Integrum AB, a public company listed on First North, NASDAQ, Stockholm, Sweden, and one of the most experienced osseointegration orthopaedic surgeons in the world. He was the lead surgeon for the team that in 2013 treated a patient with an above elbow amputation with a combination of a percutaneous osseointegrated implant and implanted muscle and nerve electrodes. He received the Hanger prize for his contribution to amputee treatment in 2007, the UCSF Presidential Chair Award in 2016, the Brian and Joyce Blatchford Prize in 2017, the Per Udde’n Prize in 2017, and the Henry Wallman Prize in 2019. He has published more than 80 scientific peer-reviewed papers on different aspects of osseointegration ranging from material properties to in-depth patient interviews, focusing on clinical outcomes, biomechanics and interface analysis.

Title of qualification awarded
Medical Degree at University of Bologna 18/09/2008 with 110/110 cum laude.
Board of Orthopedics at Istituto Ortopedico Rizzoli, University of Bologna, 8/07/2014 with 110/110 cum laude.
Ph. D. in Oncology 11/05/2015.
From June 2015 to December 2016 she worked as orthopedics and traumatology surgeon at Department of Orthopedics and Traumathology, Ospedale Infermi, Rimini, Italy.
Since December 2016 she works at Department of Orthopedics and Orthopedic Oncology, University of Padova, Italy.

Work experiences
From October 2014 to June 2015 Researcher at University of Bologna, Dept. of Scienze Biomediche e Neuromotorie, working as staff surgeon at the Istituto Ortopedico Rizzoli.
From June 2015 to December 2016 Orthopaedic Surgeon at Infermi Hospital, Rimini, Italy.
Since December 2016 Orthopedic Surgeon, Department of Orthopedics and Orthopedic Oncology, University of Padova.
Surgical Activity: she performed more than 600 surgical procedures in orthopedics, as primary or assistant surgeon.

Awards
SIOT Award 2011,Rimini with the paper: "Distal femur reconstruction with modular prostheses: analysis of survival of implants".
EFORT Award for the Best paper June 2012, Berlin with the paper "Post radiation sarcoma: A single institutional experience on 52 cases".

Teaching activities
COURSE TEMAS PUNTUALES DE TRAUMATOLOGΜA. Caracas,Venezuela, 21-22 Febbraio 2013.
Patologie oncologiche muscolo scheletriche trattate in 2° Clinica. Docente E. Pala. 05/02/2015 Istituto Ortopedico Rizzoli, Bologna.
Corso di perfezionamento in anatomia clinica dell'apparato muscoloscheletrico anca ginocchio. 15-19 Maggio 2018. Padova.
Teacher at MOC (Musculo-Skeleteal Oncology Course) 2017
Teacher at MOC (Musculo-Skeleteal Oncology Course) 2018
Teacher at MOC (Musculo-Skeleteal Oncology Course) 2019
1st Musculoskeletal Oncology Course Sarajevo - Dec 17-18, 2019 Sarajevo.
Teacher at 4th MOC (Musculo-Skeleteal Oncology Course) 11-12 November 2021

Scientific Activities
Publications: She is the author of 52 scientific papers on National or International Journals. She is the author of more than 400 abstract for congress or meetings.
Total citation 2248, H-index 27, i10-index 36.
Congresses and Meetings: She attended more than 70 National and International Meetings. She has been a speaker or lecturer in more than 30 National or International Congresses or Scientific Meetings.
Reviewer for the following Journals: European Journal of Orthopaedic Surgery & Traumatology, EJOST.
Society Memberhip: Societΰ Italiana di Ortopedia e Traumatologia (SIOT), International Society Of Limb Salvage (ISOLS) since 2017, Co-Chair of ISOLS young member's initiative since 2018, CIOSM (Club Italiano Oncologia Muscolo Scheletrica), EMSOS (European Musculo Skeletal Oncology Society) since 2019

Collaboration in textbooks
La riabilitazione dei pazienti operati per neoplasie primitive dell'osso. 1a edizione, 2017. ISBN: 978-88-97162-62-9. Autori: Maria Grazia Benedetti, Alessandro Zati, Elisabetta Mariani, Pietro Ruggieri. Con la collaborazione di: Teresa Calabrς, Mattia Morri, Elisa Pala, Alessandro Valent.
La protesizzazione nelle neoplasie primitive dell'anca. Le protesi complesse d'anca. Primo impianto. Le protesi complesse d'anca. S. Candiotto-P. Ruggieri. Timeo Editore 2022
La protesizzazione delle lesioni secondarie dell'anca. Le protesi complesse d'anca. Primo impianto. Le protesi complesse d'anca. S. Candiotto-P. Ruggieri. Timeo Editore 2022

Clinical and/or Scientific interests
Main Fields of Research: Musculoskeletal Oncology, Reconstructive Surgery, Prostheses in Musculoskeletal Oncology, Traumathology

Affiliation:
Professor of Orthopedic Surgery
Colegio de Ciencias Médicas (COCSA)
Universidad San Francisco de Quito (USFQ)
Quito - Ecuador

Orthopedic Surgeon
Orthopedic Oncologist
Department of Orthopedics and Traumatology
Hospital Metropolitano
Quito - Ecuador

Member of the Education and Fellowship Committee
International Society of Limb Salvage (ISOLS)

Treasurer
Sociedad Latinoamericana de Tumores Musculo Esqueléticos (SLATME)

Biographical Note
I am an Orthopaedic and Traumatology Professor at the University San Francisco de Quito in Ecuador. Also, I am an Orthopedic Surgen and a Orthopedic Oncologist at Hospital Metropolitano (Quito - Ecuador) known for my clinical expertise and investigations in the field of limb preservation. I work in the application of allografts and endoprosthetic reconstructions to treat musculoskeletal tumors. I also work with 3D virtual reality simulation, 3D-printing models, computer preoperative planning and computer navigation for musculoskeletal tumors. I have lectured nationally and internationally in this field. I have numerous publications in peer-reviewed journals.
I am active in a number of professional societies, serving as treasurer in the Latin American Musculoskeletal Society (SLATME) and member of the Education and Fellowship Committee in the International Society of Limb Salvage (ISOLS).